Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by analysts at Barclays from $20.00 to $26.00 in a report released on Monday, MarketBeat Ratings reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price target suggests a potential upside of 11.44% from the company’s previous close. Other equities […]
Twist Bioscience (NASDAQ:TWST – Free Report) had its target price increased by Robert W. Baird from $18.00 to $27.00 in a report published on Monday morning, FlyOnTheWall reports. TWST has been the subject of a number of other research reports. The Goldman Sachs Group lowered their price target on shares of Twist Bioscience from $43.00 […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) issued its quarterly earnings results on Friday. The company reported ($1.01) EPS for the quarter, topping analysts’ consensus estimates of ($1.14) by $0.13, Briefing.com reports. The business had revenue of $63.80 million for the quarter, compared to analyst estimates of $60.62 million. Twist Bioscience had a negative return […]
By Adriano Marchese Twist Bioscience shares traded higher after reporting better-than-expected loss and revenue growth in its fiscal third quarter. At 1:44.
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report)’s share price fell 3% during mid-day trading on Monday . The stock traded as low as $23.26 and last traded at $24.25. 359,345 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 1,262,602 shares. The stock had previously closed at […]